Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
MBRX similar filings
- 21 Jun 21 Moleculin Announces First Subject Enrolled and Dosed in Phase 1b/2 Clinical Trial of Annamycin for the Treatment of Sarcoma Lung Metastases
- 28 May 21 Submission of Matters to a Vote of Security Holders
- 25 May 21 Moleculin Commences Phase 1b/2 Clinical Trial of Annamycin for the Treatment of Sarcoma Lung Metastases
- 19 May 21 Regulation FD Disclosure
- 13 May 21 Other Events
- 12 May 21 Moleculin Reports First Quarter 2021 Financial Results and Provides Programs Update
- 14 Apr 21 Moleculin Awarded New Rare Pediatric Disease Designation from U.S. FDA for WP1066 for the Treatment of Ependymoma
Filing view
External links
Exhibit 99.1